Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21475295 | 0.85 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL21475318 | 0.82 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL21475384 | 0.81 | SMN1; SMN2 (0.30) | SMN1; SMN2 | |
| SCHEMBL21475343 | 0.81 | PRKCA (0.31) | SMN1; SMN2 | |
| SCHEMBL21475287 | 0.81 | PRKCA (0.31) | SMN1; SMN2 | |
| SCHEMBL23007987 | 0.81 | PRKCA (0.31) | SMN1; SMN2 | |
| SCHEMBL21475409 | 0.81 | SMN1; SMN2 (0.30) | SMN1; SMN2 | |
| SCHEMBL21479494 | 0.81 | ICAM1 (0.39) | — | |
| SCHEMBL23007989 | 0.81 | ICAM1 (0.39) | — | |
| SCHEMBL21479491 | 0.81 | ICAM1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210047283-A1 | NOVEL LACTONE COMPOUND AND NOVEL ETHER COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-02-18 | — | — | US | disclosed |
| EP-3778581-A1 | NOVEL LACTONE COMPOUND AND NOVEL ETHER COMPOUND | Takasago International Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| WO-2019198678-A1 | NOVEL LACTONE COMPOUND AND NOVEL ETHER COMPOUND | 高砂香料工業株式会社 | 2019-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047283-A1 | NOVEL LACTONE COMPOUND AND NOVEL ETHER COMPOUND | NR0B1, CBR1, DCXR | SMN1; SMN2 4628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.